Chondroblastoma's Lung Metastases Treated with Denosumab in Pediatric Patient

Research output: Contribution to journalArticlepeer-review


Chondroblastoma is a rare benign chondrogenic tumor that occurs in skeletally immature patients between ages 10 and 20 years old. In literature are reported few cases of lung metastases, mainly occurred after surgery or local recurrences. There is no evidence on the pathogenesis of lung metastasis, as well as pulmonary disease course. Few treatments for metastases with aggressive behavior were based on chemotherapy regimen employed in other sarcoma with no results or not satisfying ones. Denosumab is approved for treatment of giant cell tumors and it is under investigation for other giant cell-rich bone tumors. Here, we report a case of a 16-year-old male chondroblastoma of the left humerus with bilateral lung metastases at presentation and progressing during follow-up, treated with denosumab for almost 2 years. We confirm that denosumab treatment can be effective in controlling chondroblastoma metastasis and it has been a safe procedure in an adolescent patient.

Original languageEnglish
Pages (from-to)279-282
Number of pages4
JournalCancer Research and Treatment
Issue number1
Publication statusPublished - 2021


  • Chemotherapy
  • Chondroblastoma
  • Denosumab
  • Lung
  • Metastasis
  • Pediatric


Dive into the research topics of 'Chondroblastoma's Lung Metastases Treated with Denosumab in Pediatric Patient'. Together they form a unique fingerprint.

Cite this